Alzheimer's trial results lend momentum to drugs targeting tau.
Where this comes from
- Record sourced from PubMed, PMID 42490471.
- Also identified by DOI 10.1126/science.aek8032.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
First drug to lower the protein and slow cognitive decline created buzz despite puzzling data.
Medical subject headings
- tau Proteins
- Alzheimer Disease